Lorundrostat, a hypertension drug from Mineralys Therapeutics, has shown positive results in two pivotal trials for the treatment of uncontrolled or resistant hypertension the company announced on Monday. Both trials met their primary endpoints and had good safety and tolerability results. “This is a significant outcome” for about 20 million people with uncontrolled hypertension in […]
The post Positive Topline Results for Lorundrostat in Hypertension first appeared on News Health.
Author : News Health
Publish date : 2025-03-12 19:30:00
Copyright for syndicated content belongs to the linked Source.